S · Spot the signal
Document what happened and distinguish facts from assumptions.
SIGNAL Managed Monitoring
When the same issue shows up across oncology sites, a Lampgen oversight lead connects the findings, brings one recommendation to the sponsor, and checks whether the issue recurs after action.
Your monitoring team already records findings. The hard part starts when the same issue appears at several sites and your lead has to piece together what happened, what decision is needed, and when to check the result.
In SIGNAL Managed Monitoring, a named Lampgen oversight lead reviews selected reports, links related findings to the records behind them, and prepares a weekly sponsor decision brief. Your team makes the decision. The brief records the rationale, action owner, implementation due date, and the criterion and date for follow-up.
The service uses your approved study records and agreed escalation route. The SIGNAL Oversight Workspace prototype demonstrates how the SIGNAL™ framework connects the evidence, decision, and follow-up.
THE ORIGINAL SIGNAL™ TRAINING CASE · AUGUST 2026
Three sites report pharmacokinetic (PK) collections outside the protocol window. Should the sponsor approve a change to visit planning or investigate further? Follow the evidence behind the recommendation, then see what stays open after the action is implemented.
Prototype using fictional data only. Non-validated demo — not for real trial data.
Document what happened and distinguish facts from assumptions.
Test explanations across site workflows, protocol requirements, vendors, and systems.
Check where else the issue occurs, how often it happens, and what the affected sites have in common.
Identify what the issue could affect, including participant safety, critical data, or endpoint evaluability.
Escalate through the agreed pathway and document the action, owner, and due date.
Check whether recurrence changes after the action and use the results to inform future monitoring.
| Engagement | What you get | How we price it |
|---|---|---|
| Oncology CRA staffing | Site monitoring, report preparation, and follow-up by a CRA who fits the study. | Contract rate based on role, workload, travel, and duration. |
| Staffing + SIGNAL Managed Monitoring | CRA coverage plus cross-site findings review, a weekly sponsor decision brief, and follow-up on agreed actions. | Contract staffing rate plus a separately scoped oversight fee. |
| SIGNAL Managed Monitoring pilot | The same oversight process for a defined portion of one study using the sponsor’s existing monitoring team. | $12,000 fixed fee for a defined 90-day scope. Ongoing oversight can be quoted separately. |
We quote oversight based on the number of sites and CRAs, expected report volume, review cadence, and escalation coverage. We confirm travel and any work outside the agreed scope separately.
The $12,000 fixed-fee, 90-day SIGNAL Managed Monitoring pilot covers one oncology study, one to three existing CRAs, up to six sites, and up to 12 selected reports per month. Before kickoff, we agree on the systems approved by the sponsor for live work, decision owners, and escalation route. Additional CRA coverage can be quoted separately.
By day 30
Confirm the sites, CRA assignments, reports in scope, escalation contacts, and required access. Agree on one recurring issue and establish how the team prepares decisions and checks follow-up today.
By day 60
Review selected reports weekly. Bring related findings and a recommendation to the sponsor, then record its decision, action owner, and follow-up date.
By day 90
Review decision preparation time, evidence completeness, and the disposition of due effectiveness checks. Agree on handoff or continued coverage.
The sponsor retains oversight responsibility and decision authority. Urgent findings follow the sponsor’s escalation route as they arise. For a fit call, bring one recurring issue and describe how your team made and revisited the last decision.
Request a 15-minute pilot fit callFor oncology sponsors and CROs
Answer four questions to see which staffing or oversight model could fit your next milestone. See your result before sharing contact details.
Use general study needs. Leave patient information and confidential protocol details out of your inquiry.
FOR ONCOLOGY SPONSORS
Request a fictional sponsor dashboard showing the evidence behind a recommendation, the action owner, and what remains open at follow-up.